Dopamine D4 receptor subtypes and response to clozapine. 1993

S Shaikh, and D Collier, and R W Kerwin, and L S Pilowsky, and M Gill, and W M Xu, and A Thornton

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D003024 Clozapine A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent. Clozaril,Leponex
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain
D017448 Receptors, Dopamine D2 A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D2-class receptor genes contain INTRONS, and the receptors inhibit ADENYLYL CYCLASES. Dopamine D2 Receptors,Dopamine-D2 Receptor,D2 Receptors, Dopamine,Dopamine D2 Receptor,Receptor, Dopamine-D2
D050638 Receptors, Dopamine D4 A subtype of dopamine D2 receptors that has high affinity for the antipsychotic CLOZAPINE. Dopamine D4 Receptors,Dopamine D4 Receptor,Receptor, Dopamine D4,D4 Receptor, Dopamine,D4 Receptors, Dopamine

Related Publications

S Shaikh, and D Collier, and R W Kerwin, and L S Pilowsky, and M Gill, and W M Xu, and A Thornton
June 1996, Ugeskrift for laeger,
S Shaikh, and D Collier, and R W Kerwin, and L S Pilowsky, and M Gill, and W M Xu, and A Thornton
November 2005, The International journal of neuroscience,
S Shaikh, and D Collier, and R W Kerwin, and L S Pilowsky, and M Gill, and W M Xu, and A Thornton
January 1995, Life sciences,
S Shaikh, and D Collier, and R W Kerwin, and L S Pilowsky, and M Gill, and W M Xu, and A Thornton
November 1994, Archives of general psychiatry,
S Shaikh, and D Collier, and R W Kerwin, and L S Pilowsky, and M Gill, and W M Xu, and A Thornton
September 1997, Neuroscience and biobehavioral reviews,
S Shaikh, and D Collier, and R W Kerwin, and L S Pilowsky, and M Gill, and W M Xu, and A Thornton
April 2012, Progress in neuro-psychopharmacology & biological psychiatry,
S Shaikh, and D Collier, and R W Kerwin, and L S Pilowsky, and M Gill, and W M Xu, and A Thornton
February 1997, European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,
S Shaikh, and D Collier, and R W Kerwin, and L S Pilowsky, and M Gill, and W M Xu, and A Thornton
January 1996, American journal of medical genetics,
S Shaikh, and D Collier, and R W Kerwin, and L S Pilowsky, and M Gill, and W M Xu, and A Thornton
January 1999, Psychopharmacology,
S Shaikh, and D Collier, and R W Kerwin, and L S Pilowsky, and M Gill, and W M Xu, and A Thornton
February 1995, European journal of pharmacology,
Copied contents to your clipboard!